LEXARIA BIOSCIENCE CORP. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3250ff41-bcca-4973-9f66-70335e65e3fd/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-11.9M | 2024-09-01 – 2025-08-31 | evidence 0001640334-25-002225 |
| FY 2024 | $-5.8M | 2023-09-01 – 2024-08-31 | evidence 0001640334-24-001787 |
| FY 2023 | $-6.5M | 2022-09-01 – 2023-08-31 | evidence 0001640334-23-002227 |
| FY 2022 | $-6.6M | 2021-09-01 – 2022-08-31 | evidence 0001640334-23-002227 |
| FY 2021 | $-5.7M | 2020-09-01 – 2021-08-31 | evidence 0001640334-22-002512 |
| FY 2016 | $-1.3M | 2015-09-01 – 2016-08-31 | evidence 0001062993-16-012493 |
| FY 2015 | $-2.0M | 2014-09-01 – 2015-08-31 | evidence 0001062993-15-006451 |
| FY 2014 | $-1.6M | 2013-09-01 – 2014-08-31 | evidence 0001062993-15-006451 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).